Nicardipine Hydrochloride Injection
Product Images NDC 69097-008

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nicardipine Hydrochloride (NDC 69097-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch-label-20mg (Pouch Label 20mg)

Label for NICARDIPINE HYDROCHLORIDE Injection 20 mg in 200 mL (0.1 mg/mL) in 0.9% Sodium Chloride for intravenous infusion. Sterile, nonpyrogenic solution in a single dose container. Manufactured by Cipla USA Inc. with storage and usage instructions included. NDC 69097-007-45.*

FDA Label Image

Pouch-label-40mg (Pouch Label 40mg)

Label for NICARDIPINE HYDROCHLORIDE Injection 0.2 mg/mL in 0.9% Sodium Chloride, 40 mg in 200 mL sterile, nonpyrogenic intravenous infusion. Manufactured by Cipla Ltd. and Cipla USA Inc., distributed from New Jersey. The label includes dosage, storage instructions, and caution statements.*

FDA Label Image

Structure (Structure)

Chemical structure of nicardipine hydrochloride, showing detailed molecular components including aromatic rings, nitro groups, and hydrochloride component with molecular formula C26H29N3O6.HCl.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.